+91-6280082254
Reviewed by
Dr. Lovedeep Singh Chauhan, MS, MCh (Surgical Oncology) | Senior Surgical Oncologist Trained at Tata Memorial Hospital, Mumbai Practicing at Max Super Speciality Hospital, Mohali This article is written for patient education purposes only and does not constitute personal medical advice.
Introduction
After cancer surgery or a biopsy, one of the most important documents you will receive is the histopathology report, sometimes also called a biopsy report or pathology report. For most patients, this report feels like it is written in a completely different language. Terms like "moderately differentiated," "clear margins," "lymphovascular invasion," and "Ki-67 index" can feel deeply confusing and frightening when you are already under enormous stress.
This guide explains each major section of a histopathology report in plain, clear language. Understanding your report will help you have a more meaningful conversation with your surgical oncologist , ask the right questions, and feel less overwhelmed by the information you have received.
Patients consulting Dr. Lovedeep Singh Chauhan, a surgical oncologist in Punjab , from across the region—including Ludhiana , Patiala, and Chandigarh frequently bring their histopathology reports to their first appointment with significant anxiety. This guide is written specifically to address those concerns before that consultation.
What Is a Histopathology Report?
A histopathology report is a detailed laboratory analysis of tissue removed from your body either through a biopsy (a small sample taken before surgery) or from the surgical specimen removed during an operation.
A specialist doctor called a pathologist examines the tissue under a microscope and prepares a written report describing exactly what the cells look like, how abnormal they are, and what their behaviour suggests about the cancer. This report is not written by your surgeon; it comes from the pathology laboratory, usually within 5–10 working days after the tissue is submitted.
The histopathology report is one of the most important documents in cancer treatment. It directly guides decisions about whether further surgery is needed, whether chemotherapy or radiation will be recommended, and what the overall prognosis looks like.
Section 1: The Diagnosis Line
The first key section of your report states the diagnosis of what type of cancer is present and where it originated. Common examples include:
"Invasive ductal carcinoma of the breast" meaning a breast cancer that has grown beyond the ducts into surrounding breast tissue.
"Moderately differentiated adenocarcinoma of the rectum" meaning a rectal cancer arising from gland-forming cells, with moderate abnormality in cell appearance.
"Papillary thyroid carcinoma" a common and typically well-behaved type of thyroid cancer, frequently treated by Dr. Lovedeep Singh Chauhan as part of his endocrine malignancy practice.
The diagnosis line tells you the cancer type and the tissue of origin. If your diagnosis mentions a body part and a cell type together (such as "squamous cell carcinoma of the cervix"), both parts matter and your oncologist will explain what they mean for your treatment.
Section 2: Tumour Grade - What It Means
Tumour grade describes how abnormal the cancer cells look under the microscope compared to normal, healthy cells. It is one of the most important pieces of information in the report because it reflects how aggressively the cancer is likely to behave.
Grading is usually reported as Grade 1, 2, or 3 or in equivalent descriptive terms:
Grade 1 - Well Differentiated The cancer cells still look fairly similar to normal cells. They tend to grow slowly and are generally considered lower risk. This is the most favourable grade.
Grade 2 - Moderately Differentiated The cancer cells look noticeably abnormal but not completely unrecognisable. They grow at a moderate pace. This is the most commonly reported grade across many cancer types.
Grade 3 - Poorly Differentiated The cancer cells look very abnormal and bear little resemblance to normal tissue. They tend to grow and spread more quickly. A Grade 3 result does not automatically mean the cancer cannot be treated, it means the treatment plan needs to be more aggressive and comprehensive.
Some reports use additional grading systems specific to certain cancers. Breast cancer reports use the Nottingham Grading System, which combines three separate scores (tubule formation, nuclear pleomorphism, and mitotic count) into a final grade. Prostate cancer uses the Gleason Score. Your oncologist will interpret the grading system relevant to your specific cancer type.
Section 3: Surgical Margins Clear, Close, or Involved
Surgical margins refer to the edges of the tissue that was removed during your operation. After surgery, the pathologist examines whether cancer cells are present at or near the outer edges of the removed specimen.
Here is one of the most important post-surgical questions: did the surgeon remove all the cancer?
Clear Margins (also called Negative Margins or R0 Resection) No cancer cells are seen at the edges of the removed tissue. This is the most favourable result; it means the tumour was completely removed with a rim of healthy tissue around it. This is the surgical goal in all cancer operations performed by Dr. Lovedeep Singh Chauhan.
Close Margins Cancer cells are present very near the edge of the removed tissue but not at the actual cut edge. Depending on how close, and which cancer type is involved, your oncologist may recommend radiation to that area or monitor closely. This does not automatically mean further surgery is needed.
Positive Margins (also called Involved Margins or R1 Resection) Cancer cells are seen at the actual cut edge of the removed tissue. This means some cancer cells may have been left behind in the body. Depending on the location, cancer type, and other factors, your surgical team may recommend re-operation, radiation, or a combination of treatments.
Understanding your margin status is critical before your post-surgical consultation. If your report says "margins positive," do not panic before speaking to your oncologist; the management plan depends on many other factors in the report as well.
Section 4: Lymph Node Status One of the Most Important Findings
Lymph nodes are small glands distributed throughout the body that are part of the immune system. Cancer cells often spread first to nearby lymph nodes before reaching distant organs. Examining lymph nodes removed during surgery is one of the most reliable ways to assess whether cancer has begun to spread.
Your report will typically state how many lymph nodes were examined and how many contained cancer cells, written as a fraction for example, 2/18 means cancer was found in 2 out of 18 lymph nodes examined.
Node Negative (0/X) No cancer cells found in any lymph node examined. This is a very favourable finding suggesting the cancer had not spread to the lymphatic system at the time of surgery.
Node Positive (1 or more positive nodes) Cancer cells found in one or more lymph nodes. This finding upgrades the cancer stage and typically means systemic treatment chemotherapy, targeted therapy, or hormonal therapy will be recommended in addition to surgery.
Isolated Tumour Cells or Micrometastases In some reports, the pathologist may find only a very small number of scattered cancer cells in a lymph node, described as isolated tumour cells (ITC) or micrometastases. The significance of these findings is cancer-type specific and will be discussed by your oncologist in detail.
For patients treated for colorectal cancers, gynaecological malignancies, head and neck cancers, or breast cancers all areas of Dr. Lovedeep Singh Chauhan's surgical oncology practice lymph node status is a central factor in deciding the next steps after surgery.
Section 5: Lymphovascular Invasion (LVI) and Perineural Invasion (PNI)
These two terms appear in many histopathology reports and cause significant anxiety for patients who encounter them without context.
Lymphovascular Invasion (LVI) This means the pathologist has found cancer cells inside small blood vessels or lymphatic channels within the removed specimen. It suggests the cancer was in the process of, or capable of, travelling beyond the primary tumour site. LVI positive findings often influence decisions about additional (adjuvant) treatment after surgery.
Perineural Invasion (PNI) This means cancer cells have been found tracking along nerve fibres within the specimen. PNI is associated with a higher risk of local recurrence in some cancer types and may influence radiation planning. It is particularly relevant in head and neck cancers and certain colorectal and pancreatic cancers.
Neither LVI nor PNI alone determines your outcome. They are risk factors that help your oncologist build the most appropriate treatment plan for your specific situation.
Section 6: TNM Staging Based on Pathology
Your histopathology report will often include a pathological TNM stage, written as pT, pN, and pM the "p" standing for "pathological" (meaning confirmed by microscopic examination, as opposed to clinical staging done on imaging alone).
pT - Pathological Tumour Size and Local Extent This describes how large the tumour was and how deeply it had grown into surrounding tissue layers. T1 is the earliest and most localised; T4 indicates the tumour has grown into adjacent structures.
pN - Pathological Node Status This reflects the lymph node findings described in Section 4. N0 means no nodes involved; N1, N2, N3 indicate increasing numbers or locations of involved nodes depending on the cancer type.
pM - Pathological Metastasis This indicates whether distant spread (to liver, lungs, bones, or other organs) was confirmed pathologically. In most surgical specimens, pM is not assessed unless distant tissue was also biopsied.
[→ Read our Oncology Glossary: Understanding TNM Staging, Grade, and Tumor Markers for a complete breakdown of staging terminology]
Section 7: Hormone Receptor Status and Molecular Markers
For breast cancer patients in particular, the histopathology report includes additional molecular information that directly guides treatment decisions.
ER and PR Status (Oestrogen and Progesterone Receptors) If the cancer cells have receptors for oestrogen or progesterone, the cancer is described as ER-positive or PR-positive. This is generally a favourable finding as it means the cancer can be treated with hormonal therapies like tamoxifen or aromatase inhibitors.
HER2 Status HER2 is a protein that promotes cancer cell growth. HER2-positive breast cancers tend to be more aggressive but respond well to targeted drugs like trastuzumab (Herceptin). HER2-negative cancers do not carry this receptor.
Ki-67 Index Ki-67 is a marker of how rapidly the cancer cells are dividing. A low Ki-67 (under 15–20%) suggests slower-growing cancer; a high Ki-67 suggests more aggressive cell proliferation. This number helps guide decisions about whether chemotherapy is needed even when nodes are negative.
For urological malignancies such as prostate cancer, the report may include a Gleason Score or Grade Group instead of conventional grading. For thyroid and endocrine malignancies, specific features like capsular invasion and vascular invasion are the key pathological findings your surgeon will focus on.
Section 8: What to Do After Reading Your Report
Reading a histopathology report alone, without medical guidance, almost always creates more anxiety than clarity. Here is how to approach the report constructively:
Do not search individual terms on the internet in isolation; the meaning of each finding depends on the complete picture of your report, your cancer type, and your overall clinical situation.
Write down every term you do not understand and bring the list to your oncologist appointment. A good surgical oncologist will go through each finding with you and explain what it means for your specific treatment plan.
Bring your original report and any imaging (CT, MRI, PET-CT) to the same appointment. Bring a family member or trusted person who can help remember what is said during a consultation that covers a lot of medical ground.
If you are travelling from areas like Kharar, Zirakpur, or Ropar for your follow-up consultation, arrange for sufficient time post-surgical pathology discussions that often take longer than a standard appointment and deserve your full attention.
[→ Read our guide: What to Do After Receiving a Cancer Diagnosis — First 7 Steps Explained]
Frequently Asked Questions (FAQs)
Dr. Lovedeep Singh Chauhan
Dr. Lovedeep Singh Chauhan is a Consultant in Surgical Oncology at Max Super Speciality Hospital, Mohali (2023–present). He has received advanced training in cancer surgery from leading national institutes and has academic, clinical, and research experience across multiple subspecialties of surgical oncology.
>
